HONG KONG – Johnson & Johnson Innovation LLC has set up a partnering office at the newly opened Seoul Bio Hub to help emerging biotech startups. Read More

SHANGHAI – Shanghai-based Ark Biosciences Inc., a virtual biotech, and the California Institute of Biomedical Research (Calibr), of La Jolla, an affiliate of The Scripps Research Institute (TSRI), one of the world's largest private biomedical research institutes, have partnered to develop preclinical assets for chronic obstructive pulmonary disease (COPD). Read More

The creation of a new microdevice that allows generation of three-dimensional (3-D) axonal structures from human stem cell-derived neurons should facilitate future studies on axon development and allow drug screening for diseases including amyotrophic lateral sclerosis (ALS), a new study has found. Read More

HONG KONG – Enleofen Bio Pte Ltd., of Singapore, said it has discovered a key target for the treatment of fibrosis, which could significantly improve the therapies by offering more effective options with fewer side effects to the patients. Read More

SHANGHAI – Genhui Chen, CEO and co-founder of Beijing Wenfeng Tianji Pharma Ltd., is at the end of a long road. He is an inventor-entrepreneur waiting patiently for the CFDA to give him the good news he is hoping for: that benvitimod, the first-in-class small-molecule drug he has been developing since the late 1990s, will be approved for mild to moderate psoriasis in China. Read More

Aslan Pharmaceuticals Pte. Ltd., of Singapore, said its IND to run a phase II trial of ASLAN-003 in patients with acute myeloid leukemia was approved by Singapore's Health Sciences Authority. The primary outcome of the dose-optimization study is overall complete remission rate. Read More

Vyome Biosciences Pvt Ltd., of New Delhi, India, appointed Charles G. Chavdarian senior vice president of product development and regulatory CMC (chemistry, manufacturing and controls), and named Angelo Secci chief medical officer. Read More